International ALLIANCE Study of Therapies to Prevent Progression of COVID-19
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
COVID-19 is a global pandemic. So far encouraging results have been shown in different parts
of the world with the utilisation of hydroxycloroquine, zinc, and azithromycin, and early
studies into some of these, plus some with Vitamin C, have also proven beneficial. Vitamin D
levels have also been shown to be an important indicator to the severity of symptoms in
COVID-19 patients.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Integrative Medicine, Australia
Collaborator:
Catholic Health Initiatives
Treatments:
Ascorbic Acid Azithromycin Cholecalciferol Hydroxocobalamin Hydroxychloroquine Vitamin B 12 Vitamin D Vitamins